Patents by Inventor John Fitzmaurice

John Fitzmaurice has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Residualizing linkers and uses thereof
    Patent number: 11793895
    Abstract: The present invention relates to conjugates including a residualizing linker, methods for their production, and uses thereof.
    Type: Grant
    Filed: July 24, 2020
    Date of Patent: October 24, 2023
    Inventors: John Fitzmaurice Valliant, Eric Steven Burak, Neil G. Cockburn, Alla Darwish, Joel A. Drewry, John R. Forbes, Meiduo Hu, Ryan W. Simms, Karin A. Stephenson, Tao Wu
  • RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY
    Publication number: 20230270895
    Abstract: Combination therapies comprising administering radioimmunoconjugates and one or more checkpoint inhibitors.
    Type: Application
    Filed: August 15, 2022
    Publication date: August 31, 2023
    Inventors: Eric Steven Burak, Julie Metcalf, Natalie Grinshtein, Meiduo Hu, John Fitzmaurice Valliant
  • IGF-1R MONOCLONAL ANTIBODIES AND USES THEREOF
    Publication number: 20230052140
    Abstract: The present invention relates to conjugates including a chelating moiety of a metal complex thereof and a therapeutic or targeting moiety, methods for their production, and uses thereof.
    Type: Application
    Filed: July 28, 2022
    Publication date: February 16, 2023
    Inventors: Eric Steven Burak, John Richard Forbes, Matthew David Burr Moran, Ryan Wayne Simms, John Fitzmaurice Valliant, Alla Darwish
  • Actinium-225 and checkpoint inhibitor combination therapy
    Patent number: 11446401
    Abstract: Combination therapies comprising administering radioimmunoconjugates and one or more checkpoint inhibitors.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: September 20, 2022
    Assignee: Fusion Pharmaceuticals Inc.
    Inventors: Eric Steven Burak, Julie Metcalf, Natalie Grinshtein, Meiduo Hu, John Fitzmaurice Valliant
  • IGF-1R monoclonal antibodies and uses thereof
    Patent number: 11433148
    Abstract: The present invention relates to conjugates including a chelating moiety of a metal complex thereof and a therapeutic or targeting moiety, methods for their production, and uses thereof.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: September 6, 2022
    Assignee: Centre for Probe Development and Commercialization
    Inventors: Eric Steven Burak, John Richard Forbes, Matthew David Burr Moran, Ryan Wayne Simms, John Fitzmaurice Valliant, Alla Darwish
  • RADIOIMMUNOCONJUGATES AND DNA DAMAGE AND REPAIR INHIBITOR COMBINATION THERAPY
    Publication number: 20220088231
    Abstract: Combination therapies comprising administering radioimmunoconjugates and DNA damage response inhibitors.
    Type: Application
    Filed: December 3, 2019
    Publication date: March 24, 2022
    Inventors: Eric Steven BURAK, John Richard FORBES, Meiduo HU, John Fitzmaurice VALLIANT
  • RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY
    Publication number: 20220088230
    Abstract: Combination therapies comprising administering radioimmunoconjugates and one or more checkpoint inhibitors.
    Type: Application
    Filed: December 3, 2019
    Publication date: March 24, 2022
    Inventors: Eric Steven BURAK, Julie METCALF, Natalie GRINSHTEIN, Meiduo HU, John Fitzmaurice VALLIANT
  • PHARMACOKINETIC ENHANCEMENTS OF BIFUNCTIONAL CHELATES AND USES THEREOF
    Publication number: 20220054664
    Abstract: The present invention relates to conjugates including a chelating moiety of a metal complex thereof and a therapeutic or targeting moiety, methods for their production, and uses thereof.
    Type: Application
    Filed: November 2, 2021
    Publication date: February 24, 2022
    Inventors: Eric Steven Burak, Stuart James Mahoney, Ryan Wayne Simms, John Fitzmaurice Valliant, Alla Darwish
  • Pharmacokinetic enhancements of bifunctional chelates and uses thereof
    Patent number: 11191854
    Abstract: The present invention relates to conjugates including a chelating moiety of a metal complex thereof and a therapeutic or targeting moiety, methods for their production, and uses thereof.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: December 7, 2021
    Assignee: Centre for Probe Development and Commercialization
    Inventors: Eric Steven Burak, Stuart James Mahoney, Ryan Wayne Simms, John Fitzmaurice Valliant, Alla Darwish
  • RADIOIMMUNOCONJUGATES AND DNA DAMAGE AND REPAIR INHIBITOR COMBINATION THERAPY
    Publication number: 20210290788
    Abstract: Combination therapies comprising administering radioimmunoconjugates and DNA damage response inhibitors.
    Type: Application
    Filed: June 2, 2021
    Publication date: September 23, 2021
    Inventors: Eric Steven Burak, John Richard Forbes, Meiduo Hu, John Fitzmaurice Valliant
  • RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY
    Publication number: 20210290789
    Abstract: Combination therapies comprising administering radioimmunoconjugates and one or more checkpoint inhibitors.
    Type: Application
    Filed: June 2, 2021
    Publication date: September 23, 2021
    Inventors: Eric Steven Burak, Julie Metcalf, Natalie Grinshtein, Meiduo Hu, John Fitzmaurice Valliant
  • RESIDUALIZING LINKERS AND USES THEREOF
    Publication number: 20210060190
    Abstract: The present invention relates to conjugates including a residualizing linker, methods for their production, and uses thereof.
    Type: Application
    Filed: July 24, 2020
    Publication date: March 4, 2021
    Inventors: John Fitzmaurice Valliant, Eric Steven Burak, Neil Grant Cockbum, Alla Darwish, Joe Adamson Drewry, John Richard Forbes, Meiduo Hu, Ryan Wayne Simms, Karin Ann Stephenson, Tao Wu
  • Residualizing linkers and uses thereof
    Patent number: 10758636
    Abstract: The present invention relates to conjugates including a residualizing linker, methods for their production, and uses thereof.
    Type: Grant
    Filed: November 12, 2014
    Date of Patent: September 1, 2020
    Assignee: CENTRE FOR PROBE DEVELOPMENT AND COMMERCIALIZATION
    Inventors: John Fitzmaurice Valliant, Eric Steven Burak, Neil Grant Cockburn, Alla Darwish, Joel Adamson Drewry, John Richard Forbes, Meiduo Hu, Ryan Wayne Simms, Karin Ann Stephenson, Tao Wu
  • IGF-1R MONOCLONAL ANTIBODIES AND USES THEREOF
    Publication number: 20190083662
    Abstract: The present invention relates to conjugates including a chelating moiety of a metal complex thereof and a therapeutic or targeting moiety, methods for their production, and uses thereof.
    Type: Application
    Filed: May 4, 2018
    Publication date: March 21, 2019
    Inventors: Eric Steven Burak, John Richard Forbes, Matthew David Burr Moran, Ryan Wayne Simms, John Fitzmaurice Valliant
  • PHARMACOKINETIC ENHANCEMENTS OF BIFUNCTIONAL CHELATES AND USES THEREOF
    Publication number: 20190030194
    Abstract: The present invention relates to conjugates including a chelating moiety of a metal complex thereof and a therapeutic or targeting moiety, methods for their production, and uses thereof.
    Type: Application
    Filed: May 4, 2018
    Publication date: January 31, 2019
    Inventors: Eric Steven Burak, Stuart James Mahoney, Ryan Wayne Simms, John Fitzmaurice Valliant
  • IGF-1R monoclonal antibodies and uses thereof
    Patent number: 10093741
    Abstract: The present invention relates to conjugates including a chelating moiety of a metal complex thereof and a therapeutic or targeting moiety, methods for their production, and uses thereof.
    Type: Grant
    Filed: August 15, 2017
    Date of Patent: October 9, 2018
    Assignee: Fusion Pharmaceuticals Inc.
    Inventors: Eric Steven Burak, John Richard Forbes, Matthew David Burr Moran, Ryan Wayne Simms, John Fitzmaurice Valliant
  • RESIDUALIZING LINKERS AND USES THEREOF
    Publication number: 20160279272
    Abstract: The present invention relates to conjugates including a residualizing linker, methods for their production, and uses thereof.
    Type: Application
    Filed: November 12, 2014
    Publication date: September 29, 2016
    Inventors: John Fitzmaurice VALLIANT, Eric Steven BURAK, Neil Grant COCKBURN, Alla DARWISH, Joel Adamson DREWRY, John Richard FORBES, Meiduo HU, Ryan Wayne SIMMS, Karin Ann STEPHENSON, Tao WU
  • Manufactured home
    Patent number: D910874
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: February 16, 2021
    Assignee: JCF/IP, LLC
    Inventor: John Fitzmaurice
  • Manufactured home
    Patent number: D910875
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: February 16, 2021
    Assignee: JCF/IP, LLC
    Inventor: John Fitzmaurice
  • Manufactured home
    Patent number: D920539
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: May 25, 2021
    Assignee: JCF/IP, LLC
    Inventor: John Fitzmaurice